Suppr超能文献

阿立哌唑治疗舒必利所致迟发性口下颌肌张力障碍的疗效。

Efficacy of aripiprazole in sulpiride-induced tardive oromandibular dystonia.

作者信息

Imai Noboru, Ikawa Masako

机构信息

Department of Neurology, Shizuoka Red Cross Hospital, Japan.

出版信息

Intern Med. 2011;50(6):635-7. doi: 10.2169/internalmedicine.50.4475. Epub 2011 Mar 15.

Abstract

Tardive dystonia is a side effect of dopamine receptor-blocking agents, which are mainly used as antipsychotic drugs. The treatment of tardive dystonia is difficult and often unsuccessful. An 82-year-old woman experienced mandibular deviation to the left due to spasm of the masticatory muscles with involuntary chewing movement and Parkinsonism. She had been treated with sulpiride for motility disorder for 5 years. Parkinsonism almost disappeared after the withdrawal of sulpiride, but tardive oromandibular dystonia showed no improvement. Aripiprazole treatment at 3 mg/day improved tardive oromandibular dystonia without worsening Parkinsonism. Low-dosage aripiprazole may be effective for tardive oromandibular dystonia in patients with no other psychiatric disorder.

摘要

迟发性肌张力障碍是多巴胺受体阻断剂的一种副作用,多巴胺受体阻断剂主要用作抗精神病药物。迟发性肌张力障碍的治疗困难且常常不成功。一名82岁女性因咀嚼肌痉挛伴不自主咀嚼运动和帕金森综合征而出现下颌向左偏斜。她因运动障碍接受舒必利治疗5年。停用舒必利后帕金森综合征几乎消失,但迟发性口下颌肌张力障碍未见改善。每天3毫克阿立哌唑治疗改善了迟发性口下颌肌张力障碍,且未使帕金森综合征恶化。低剂量阿立哌唑可能对无其他精神疾病的患者的迟发性口下颌肌张力障碍有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验